Celyad Oncology SA

Celyad Oncology SA financial statements

Celyad Oncology SA's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueEUR 21KEODHD
Net incomeEUR 830KEODHD
Cash and equivalentsEUR 1.71MEODHD

Celyad Oncology SA financials on 6ix · Celyad Oncology SA on 6ix